{"id":"https://openalex.org/W1506446568","doi":"https://doi.org/10.1158/1538-7445.am2014-832","title":"Abstract 832: Pre-clinical development of EC1456: A potent Folate targeted Tubulysin SMDC","display_name":"Abstract 832: Pre-clinical development of EC1456: A potent Folate targeted Tubulysin SMDC","publication_year":2014,"publication_date":"2014-10-01","ids":{"openalex":"https://openalex.org/W1506446568","doi":"https://doi.org/10.1158/1538-7445.am2014-832","mag":"1506446568"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2014-832","doi":"https://doi.org/10.1158/1538-7445.am2014-832","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2014-832","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109996340","display_name":"Joseph A. Reddy","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I906832008","display_name":"Endocyte (United States)","ror":"https://ror.org/058dk4619","country_code":"US","type":"company","lineage":["https://openalex.org/I906832008"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joseph A. Reddy","raw_affiliation_strings":["Endocyte, Inc., West Lafayette, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Endocyte, Inc., West Lafayette, IN","institution_ids":["https://openalex.org/I906832008"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044654376","display_name":"Alicia Bloomfield","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I906832008","display_name":"Endocyte (United States)","ror":"https://ror.org/058dk4619","country_code":"US","type":"company","lineage":["https://openalex.org/I906832008"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alicia Bloomfield","raw_affiliation_strings":["Endocyte, Inc., West Lafayette, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Endocyte, Inc., West Lafayette, IN","institution_ids":["https://openalex.org/I906832008"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066599316","display_name":"Melissa Nelson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I906832008","display_name":"Endocyte (United States)","ror":"https://ror.org/058dk4619","country_code":"US","type":"company","lineage":["https://openalex.org/I906832008"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Melissa Nelson","raw_affiliation_strings":["Endocyte, Inc., West Lafayette, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Endocyte, Inc., West Lafayette, IN","institution_ids":["https://openalex.org/I906832008"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002918007","display_name":"Ryan Dorton","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I906832008","display_name":"Endocyte (United States)","ror":"https://ror.org/058dk4619","country_code":"US","type":"company","lineage":["https://openalex.org/I906832008"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ryan Dorton","raw_affiliation_strings":["Endocyte, Inc., West Lafayette, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Endocyte, Inc., West Lafayette, IN","institution_ids":["https://openalex.org/I906832008"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043457997","display_name":"Marilynn Vetzel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I906832008","display_name":"Endocyte (United States)","ror":"https://ror.org/058dk4619","country_code":"US","type":"company","lineage":["https://openalex.org/I906832008"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marilynn Vetzel","raw_affiliation_strings":["Endocyte, Inc., West Lafayette, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Endocyte, Inc., West Lafayette, IN","institution_ids":["https://openalex.org/I906832008"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5085542989","display_name":"Christopher P. Leamon","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I906832008","display_name":"Endocyte (United States)","ror":"https://ror.org/058dk4619","country_code":"US","type":"company","lineage":["https://openalex.org/I906832008"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christopher P. Leamon","raw_affiliation_strings":["Endocyte, Inc., West Lafayette, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Endocyte, Inc., West Lafayette, IN","institution_ids":["https://openalex.org/I906832008"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I906832008"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":7,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"74","issue":"19_Supplement","first_page":"832","last_page":"832"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.1729000061750412,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.1729000061750412,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.1655000001192093,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10499","display_name":"Folate and B Vitamins Research","score":0.07559999823570251,"subfield":{"id":"https://openalex.org/subfields/2916","display_name":"Nutrition and Dietetics"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tubulysin","display_name":"tubulysin","score":0.8130000233650208},{"id":"https://openalex.org/keywords/folate-receptor","display_name":"folate receptor","score":0.765999972820282},{"id":"https://openalex.org/keywords/ovarian-cancer","display_name":"ovarian cancer","score":0.7429999709129333},{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":0.7950000166893005},{"id":"https://openalex.org/keywords/lung-cancer","display_name":"lung cancer","score":0.8849999904632568},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.671999990940094},{"id":"https://openalex.org/keywords/paclitaxel-resistance","display_name":"paclitaxel resistance","score":0.9319999814033508},{"id":"https://openalex.org/keywords/cisplatin-resistance","display_name":"cisplatin resistance","score":1.0},{"id":"https://openalex.org/keywords/xenograft-models","display_name":"xenograft models","score":0.6990000009536743},{"id":"https://openalex.org/keywords/therapeutic-index","display_name":"therapeutic index","score":0.7570000290870667},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.6859999895095825},{"id":"https://openalex.org/keywords/tolerability","display_name":"tolerability","score":0.621999979019165}],"concepts":[{"id":"https://openalex.org/C2780306303","wikidata":"https://www.wikidata.org/wiki/Q24784504","display_name":"Folate receptor","level":4,"score":0.7800511121749878},{"id":"https://openalex.org/C2777292972","wikidata":"https://www.wikidata.org/wiki/Q423762","display_name":"Paclitaxel","level":3,"score":0.7041273713111877},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6238876581192017},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.5727925300598145},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5334662795066833},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.46873077750205994},{"id":"https://openalex.org/C19831878","wikidata":"https://www.wikidata.org/wiki/Q659446","display_name":"Therapeutic index","level":3,"score":0.46470609307289124},{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.4588533043861389},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4481217861175537},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.34906888008117676},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.3464866578578949},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.30334651470184326},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.19590139389038086}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2014-832","doi":"https://doi.org/10.1158/1538-7445.am2014-832","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2014-832","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2806683929","https://openalex.org/W2774970132","https://openalex.org/W2411046809","https://openalex.org/W2589125383","https://openalex.org/W2740051881","https://openalex.org/W3045965460","https://openalex.org/W2562932291","https://openalex.org/W2254346210","https://openalex.org/W2510818985","https://openalex.org/W2495706357"],"abstract_inverted_index":{"Abstract":[0],"Folate":[1,291],"targeted":[2,292],"small":[3],"molecule":[4],"drug":[5,149,218],"conjugates":[6],"(SMDC)":[7],"have":[8,33,224],"shown":[9,226],"promising":[10],"results":[11],"in":[12,22,27,75,112,185,196],"early":[13],"stage":[14],"clinical":[15,53,214,262],"trials":[16],"with":[17,66,118,173,182],"Vintafolide":[18],"now":[19,34],"being":[20],"evaluated":[21],"a":[23,36,49,122],"phase":[24],"3":[25],"trial":[26],"FR-positive":[28,220],"ovarian":[29],"cancer":[30,221],"patients.":[31],"We":[32],"developed":[35],"new":[37],"group":[38],"of":[39,43,56,77,121,212,264,287,298,303],"folate":[40,60,124,137],"conjugated":[41],"Tubulysins,":[42],"which":[44],"EC1456":[45,67,176,228,246,265],"has":[46,247],"emerged":[47],"as":[48,202],"lead":[50],"candidate":[51],"for":[52,266,307],"development.":[54],"Treatment":[55],"nude":[57],"mice":[58,79],"bearing":[59],"receptor":[61],"(FR)":[62],"positive":[63,199],"human":[64],"xenografts":[65],"led":[68],"to":[69,136,158,188,216,257],"complete":[70],"remissions":[71],"(CR's)":[72],"or":[73,96,152],"cures":[74,184,192],"100%":[76,183],"the":[78,143,146,258,299,304],"at":[80,165],"various":[81],"doses":[82],"and":[83,205,236,252],"schedules.":[84],"The":[85,131],"observed":[86,111,195],"activity":[87,106,181,251],"was":[88,110,139,156,229],"not":[89],"accompanied":[90],"by":[91,142],"any":[92],"noticeable":[93],"weight":[94],"loss":[95],"major":[97],"organ":[98],"tissue":[99],"degeneration.":[100],"In":[101,210],"contrast,":[102],"no":[103],"significant":[104,248],"anti-tumor":[105,180,249],"(0":[107],"%":[108],"CR's)":[109],"EC1456-treated":[113],"animals":[114],"that":[115,145,227,245],"were":[116,193],"co-dosed":[117],"an":[119],"excess":[120],"benign":[123],"ligand,":[125],"thus":[126,254],"demonstrating":[127],"EC1456's":[128],"target-specific":[129],"activity.":[130],"enhanced":[132],"therapeutic":[133],"index":[134],"due":[135],"conjugation":[138],"also":[140,194,225],"evidenced":[141],"fact":[144],"un-targeted":[147],"free":[148],"(tubulysin":[150],"B":[151],"its":[153],"hydrazide":[154],"form)":[155],"found":[157],"be":[159],"completely":[160],"inactive":[161],"even":[162],"when":[163,171],"administered":[164],"highly":[166,230],"toxic":[167],"dose":[168],"levels.":[169],"Furthermore,":[170],"challenged":[172],"larger":[174],"tumors,":[175],"again":[177],"displayed":[178],"remarkable":[179],"tumors":[186],"up":[187],"750":[189],"mm3.":[190],"Complete":[191],"other":[197],"FR":[198,233],"models":[200],"such":[201],"MDA-MB-231":[203],"TNBC":[204],"M109":[206],"lung":[207],"tumor":[208],"models.":[209],"support":[211,256],"our":[213],"strategy":[215],"treat":[217],"resistant":[219],"patients":[222],"we":[223],"active":[231],"against":[232],"expressing":[234],"paclitaxel":[235],"cisplatin-resistant":[237],"cell":[238],"lines.":[239],"Taken":[240],"together,":[241],"these":[242],"studies":[243],"demonstrated":[244],"growth":[250],"tolerability,":[253],"lending":[255],"ongoing":[259],"Phase":[260],"1":[261],"evaluation":[263],"advanced":[267],"malignancies.":[268],"Citation":[269],"Format:":[270],"Joseph":[271],"A.":[272],"Reddy,":[273],"Alicia":[274],"Bloomfield,":[275],"Melissa":[276],"Nelson,":[277],"Ryan":[278],"Dorton,":[279],"Marilynn":[280],"Vetzel,":[281],"Christopher":[282],"P.":[283],"Leamon.":[284],"Pre-clinical":[285],"development":[286],"EC1456:":[288],"A":[289],"potent":[290],"Tubulysin":[293],"SMDC.":[294],"[abstract].":[295],"In:":[296],"Proceedings":[297],"105th":[300],"Annual":[301],"Meeting":[302],"American":[305],"Association":[306],"Cancer":[308,319],"Research;":[309],"2014":[310],"Apr":[311],"5-9;":[312],"San":[313],"Diego,":[314],"CA.":[315],"Philadelphia":[316],"(PA):":[317],"AACR;":[318],"Res":[320],"2014;74(19":[321],"Suppl):Abstract":[322],"nr":[323],"832.":[324],"doi:10.1158/1538-7445.AM2014-832":[325]},"counts_by_year":[{"year":2018,"cited_by_count":2},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}